Cargando…

EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays

PURPOSE: To assess estradiol (E(2)) and progesterone levels during ovarian stimulation determined by third-generation (Gen III) and second-generation (Gen II) Elecsys(®) immunoassays. METHODS: E(2) and progesterone concentrations were measured using Elecsys(®) Gen III and Gen II immunoassays, and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Polyzos, N. P., Anckaert, E., Drakopoulos, P., Tournaye, H., Schiettecatte, J., Donner, H., Bobba, G., Miles, G., Verhagen-Kamerbeek, W. D. J., Bosch, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431432/
https://www.ncbi.nlm.nih.gov/pubmed/32170594
http://dx.doi.org/10.1007/s40618-020-01211-x
Descripción
Sumario:PURPOSE: To assess estradiol (E(2)) and progesterone levels during ovarian stimulation determined by third-generation (Gen III) and second-generation (Gen II) Elecsys(®) immunoassays. METHODS: E(2) and progesterone concentrations were measured using Elecsys(®) Gen III and Gen II immunoassays, and progesterone concentrations on the day of ovulation triggering were determined by LC–MS/MS. This was a retrospective, non-interventional study conducted at European tertiary referral infertility clinics in women aged 18–45 years, with a body mass index 18–35 kg/m(2), regular menses, and both ovaries. RESULTS: Serum samples were obtained from 230 women classified by oocyte retrieval as poor (33.0%; 0–3 oocytes), normal (40.9%; 4–15 oocytes), or high (26.1%; > 15 oocytes) responders. E(2) and progesterone levels increased during ovarian stimulation, with greatest increases observed in high responders. Elecsys(®) Gen III and Gen II assay results were highly correlated for E(2) (Pearson’s r = 0.99) and progesterone (r = 0.89); Gen III results were lower than Gen II for both E(2) and progesterone. On the day of triggering, Gen III E(2) and progesterone levels showed a difference of − 15.0% and − 27.9%, respectively. Progesterone levels (on day of triggering) measured by LC–MS/MS correlated better with Gen III (0.98) than Gen II (0.90). Mean relative differences for Gen III and Gen II assays versus LC–MS/MS were 14.6% and 62.8%, respectively. CONCLUSION: E(2) and progesterone levels determined with Elecsys(®) Gen II and III assays were highly correlated; results were lower for Gen III versus Gen II. Differences observed for progesterone on the day of triggering may be clinically relevant. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40618-020-01211-x) contains supplementary material, which is available to authorized users.